Gustavo A. Romero

Hospital De Gastroenterología Dr. Carlos Bonorino Udaondo
B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.

An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.

Journal: Hepatology (Baltimore, Md.)

Published: December 07, 2023

Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.

Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.

Journal: Digestive diseases and sciences

Published: September 30, 2022

MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.

MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.

Journal: JHEP reports : innovation in hepatology

Published: August 06, 2022

Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.

Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.

Journal: Journal of hepatology

Published: February 03, 2021

Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.

Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.

Journal: World journal of gastroenterology

Published: December 23, 2020

Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.

Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.

Journal: Digestive diseases and sciences

Published: June 11, 2020

Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.

Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.

Journal: World journal of gastroenterology

Published: March 19, 2019

Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?

Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?

Journal: Digestive diseases and sciences

Published: August 02, 2018

Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from Argentina.

Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from Argentina.

Journal: European journal of gastroenterology & hepatology

Published: March 07, 2018

Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina.

Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina.

Journal: World journal of hepatology

Published: October 31, 2017

Socioeconomic context of the community and chronic child malnutrition in Colombia.

Socioeconomic context of the community and chronic child malnutrition in Colombia.

Journal: Revista de saude publica

Published: December 08, 2016

Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.

Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.

Journal: Journal of medical virology

Published: November 14, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026